IGF2BP1 and colorectal carcinoma: Besides, our findings indicate a high expression of IGF2BP1 in tumor tissues (16 normal vs. 16 tumor, P < 0.001) and its association with poorer overall survival in TCGA CRC patients (P = 0.00147) (Fig. 6C-E).